Lymphoma in the Tofacitinib Rheumatoid Arthritis Clinical Development Program

por Mariette, Xavier, Chen, Connie, Biswas, Pinaki, Kwok, Kenneth, Boy, Mary G.
Publicado 2018

Risk Factors for Major Adverse Cardiovascular Events in Phase III and Long‐Term Extension Studies of Tofacitinib in Patients With Rheumatoid Arthritis

por Charles‐Schoeman, Christina, DeMasi, Ryan, Valdez, Hernan, Soma, Koshika, Hwang, Lie‐Ju, Boy, Mary G., Biswas, Pinaki, McInnes, Iain B.
Publicado 2019

Changes in serum creatinine in patients with active rheumatoid arthritis treated with tofacitinib: results from clinical trials

por Isaacs, John D, Zuckerman, Andrea, Krishnaswami, Sriram, Nduaka, Chudy, Lan, Shuping, Hutmacher, Matthew M, Boy, Mary G, Kowalski, Ken, Menon, Sujatha, Riese, Richard
Publicado 2014

Systematic review and meta-analysis of serious infections with tofacitinib and biologic disease-modifying antirheumatic drug treatment in rheumatoid arthritis clinical trials

por Strand, Vibeke, Ahadieh, Sima, French, Jonathan, Geier, Jamie, Krishnaswami, Sriram, Menon, Sujatha, Checchio, Tina, Tensfeldt, Thomas G., Hoffman, Elaine, Riese, Richard, Boy, Mary, Gómez-Reino, Juan J.
Publicado 2015